Billion dollar restatement for US drugs giant
Pharmaceuticals giant Bristol-Myers Squibb is to restate its accounts, lowering sales revenues by $2bn (£1.3bn).
Pharmaceuticals giant Bristol-Myers Squibb is to restate its accounts, lowering sales revenues by $2bn (£1.3bn).
Link: Merck misses £8bn in accounts
The restatement will affect the accounts for 2002 and 2001 and will delay publication of the company’s third quarter results. The company also said sales for 2002 should be revised upwards.
The difficulties appear to stem from challenges to the company’s revenue recognition policy.
A statement from the company said: ‘The restatement is expected to reflect primarily adjustments in the timing of revenue recognition of the company’s USpharmaceutical sales to certain of its wholesalers.’
The numbers you crunch tell a story. Your expertis...
22yEmbracing user-friendly AP systems can turn the tide, streamlining workflows, enhancing compliance, and opening doors to early payment discounts. Read...
View articleOrganisations can enhance their financial operations' efficiency, accuracy, and responsiveness by adopting platforms that offer them self-service cust...
View articleIn a world of instant results and automated workloads, the potential for AP to drive insights and transform results is enormous. But, if you’re still ...
View resourceDiscover how AP dashboards can transform your business by enhancing efficiency and accuracy in tracking key metrics, as revealed by the latest insight...
View articleThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleThis follows an investigation into undisclosed personal loans and issues with an acquisition. Despite challenges, the company aims to achieve £1bn in ...
View articleThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleThere is optimism that the IPO market will rebound in the second half of 2024, driven by pent-up demand and potential improvements in economic conditi...
View articleThe ICAEW confirms new vice president, with senior heads appointed at KPMG and EY. Within the mid market, a flurry of end of year partner appointments...
View articleKPMG confirms reappointment of it's UK chair, while EY announces Janet Truncale as the next EY global chair and CEO Read More...
View articleThe ICAEW has announced the appointment of its forthcoming chief executive Read More...
View article